Merck chief digital officer departs

Jim Scholefield has exited Merck just over a year after being hired as its chief digital officer. He is joining Marriott as chief information and digital officer. 

Fingerpaint names office lead

Michelle Petroff was promoted to lead Fingerpaint’s Conshohocken, Pa., office. She has been with Fingerpaint for 10 years and previously was head of account service and operations.

Gilead hires research biology lead

Michael Quigley has joined Gilead as head of research biology. Previously, Quigley led oncology research at Bristol-Myers Squibb. The company also promoted Linda Higgins to head of external innovation.

LaVoieHealthScience expands New York, Boston offices

Douglas Russell has become SVP for client services and PR media, Paul Sagan was promoted to VP, Lisa DeScenza was named VP and Katie Gallagher was appointed director of marketing and PR.

Evolution Health Group names EVP

Healthcare communications firm Evolution Health Group has named Michael Stevinson EVP of its blulava division. 

Amplity Health appoints three leaders

The commercialization organization named three senior leaders. Becky O’Loughlin was appointed chief people officer, Tracy Hervey was named chief commercial officer and Morayea Pindziak was named global head of marketing and communications. 

Galectin Therapeutics appoints medical chief

Pol Boudes has been named chief medical officer at Galectin Therapeutics. Boudes previously served as chief medical officer at CymaBay Therapeutics and Amicus Therapeutics.

The Escalator is a weekly roundup of notable people moves in the pharmaceutical and healthcare marketing industries. For submissions, email Carrie Gavit at